Sastasundar ventures Limited has announced that its Board of Directors will convene on February 6, 2026, to review and approve the company's quarterly financial performance. The meeting has been scheduled in compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The board meeting will focus on considering and approving the unaudited standalone and consolidated financial results for specific reporting periods. Company Secretary and Compliance Officer Pratap Singh has communicated this information to both major stock exchanges.

Trading Window Restrictions

The company has implemented trading window closure measures in accordance with regulatory guidelines. Following the earlier disclosure made on December 26, 2025, regarding trading window closure, the restrictions will continue until the financial results are officially declared.

Regulatory Compliance

The notification has been formally submitted to both BSE Limited and National Stock Exchange of India Limited. The company operates under script code 533259 on BSE and symbol SASTASUNDR on NSE. This announcement ensures compliance with SEBI's listing obligations and maintains transparency with stakeholders regarding upcoming corporate developments.

The formal communication was digitally signed by Pratap Singh, Company Secretary and Compliance Officer, on January 29, 2026, ensuring proper documentation and regulatory adherence for this corporate announcement.

Sastasundar ventures Limited has announced a postal ballot seeking shareholder approval for significant corporate changes, including a proposed name change to Health X Platform Limited and amendments to its main object clause. The company has scheduled the e-voting period from January 15, 2026, to February 13, 2026, with results to be declared by February 16, 2026.

Proposed Name Change Details

The company seeks to change its name from Sastasundar Ventures Limited to Health X Platform Limited, reflecting its strategic direction toward health-related businesses and platform-based operations. The Ministry of Corporate Affairs has already reserved the desired name "Health X Platform Limited" for the company through a letter dated January 1, 2026.

The company operates as a Core Investment Company (CIC) with subsidiaries predominantly engaged in healthcare activities. According to the consolidated financial statements for the financial year ended March 31, 2025, the majority of the company's income comes from healthcare activities through its subsidiaries.

E-Voting Schedule and Process

Shareholders can participate in the postal ballot exclusively through electronic voting, as physical ballot forms will not be distributed. The company has appointed Mr. Raj Kumar Banthia, Company Secretary in Practice (Membership No. 17190 and CP No. 18428), as the scrutinizer for conducting the postal ballot process.

Amendments to Main Object Clause

The second resolution proposes amendments to the main object clause of the company's Memorandum of Association by adding two new objects:

• Object 7: To carry on healthcare, beauty care, personal care, pharmaceuticals, wellness, diagnostics, and food business, including manufacturing, processing, marketing, trading, distribution, and related services
• Object 8: To design, develop, own, operate, manage, and maintain digital platforms and e-commerce services, including marketplace operations, trading, order fulfillment, warehousing, logistics, and data management

These additions aim to expand the company's scope to include activities relating to allied healthcare operations while maintaining its existing main objects unchanged.

Regulatory Compliance and Approvals

The company has obtained statutory auditor certification from JKVS & Co., Chartered Accountants, confirming compliance with Regulation 45(1) of the SEBI Listing Regulations. The certification, dated January 7, 2026, validates that:

• At least one year has elapsed since the last name change
• More than fifty percent of total revenue comes from activities suggested by the new name
• The company meets all prescribed conditions for name change

Both resolutions require approval through special resolutions, needing support from shareholders holding at least 75% of the votes cast. The postal ballot notice has been sent electronically to all shareholders whose email addresses are registered with the company or depositories as of the cut-off date of January 9, 2026.

Summary

Sastasundar Ventures Limited's proposed transformation to Health X Platform Limited represents a strategic alignment with its healthcare-focused business operations. The e-voting process from January 15-February 13, 2026, will determine shareholder approval for both the name change and expanded business objectives, positioning the company for enhanced operations in healthcare and digital platform services.